Neotech is an essential brand in NICU (Neonatal Intensive Care Unit) around the world which include medical devices for the PICU (Paediatric Intensive Care Unit) & children’s oncology. Their groundbreaking products benefit both patients and clinicians that focus on Making a Difference… In the NICU, PICU and Beyond.
Neotech is an essential brand in NICU (Neonatal Intensive Care Unit) around the world which include medical devices for the PICU (Paediatric Intensive Care Unit) & children’s oncology.
Designed to improve the standard of obstetric care, this new stylish design does not dominate the bedside, yet continues to offer a clear visual of the status of the fetus.
Obstetric anal sphincter injuries (OASIS) or 3rd/4th degree tears are a serious complication of childbirth that can lead to anal incontinence (AI). AI can have a devastating impact on a person’s quality of life and is perceived as a social stigma. Due to these childbirth related injuries, women are nine times more likely to develop AI compared to men.
Featuring talks from industry experts: Drug tocolysis: when and how? Prof. Dr. Werner Rath. University of Aachen and Kiel, Germany. Prediction of Preterm Delivery: looking at risk factors and biomarkers, the Belgium perspective. Dr. Caroline Van Holsbeke. ZOL, Belgium. Improving results: best practice in patient identificaion and routing. Prof. Dr. Ildar Fatkullin. University of Kazan, Russia.
In Vitro Technologies is proud to announce TGA approval for Cytocell’s Telomere range
In Vitro Technologies is proud to announce TGA approval for Cytocell’s Prenatal range
Research shows that conventional diagnostic tests, such as nitrazine (pH), ferning, pooling and ultrasound can be inaccurate and invasive. In fact Neil 2010 shows that 47% of the time clinicians are not confident in their diagnosis of PROM based on history and examination alone. The current biomarker tests to aid in detection of PROM give clinicians the certainty they need to make a confident diagnosis, quickly and easily.
Comparison of a novel test for placental alpha macroglobulin-1 with fetal fibronectin and cervical length measurement for the prediction of imminent spontaneous preterm delivery in patients with threatened preterm labor.
In a hospital emergency department, time is precious. Using AmniSure to diagnose premature rupture of fetal membranes will save you time and give you the information you need to decide if a woman should stay in hospital or go home.
No one can predict exactly when a woman will go into labour, but the new PartoSure Time to Delivery test can confidently predict the risk of a preterm birth.
When a woman presents with suspected premature rupture of the fetal membranes during pregnancy, timing and accuracy is everything. AmniSure is a non-invasive test that provides a rapid and accurate diagnosis within minutes, leading to better clinical outcomes.
Pregnancy and labour are full of uncertainty. No one can predict how a pregnancy will progress, how and when a woman will go into labour or how long her labour will last. Every woman’s experience is unique, requiring personalised care and treatment.
